Chewable tablets (EMA) [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2012-01-11 15:19 (5269 d 00:32 ago) – Posting: # 7900
Views: 9,127

Dear Jagdish!

❝ Dear HS,

   ^^ not interested in opinions of other members?


❝ can you tell me how montelukast should be administered during BE study for european submission with water after chewing or without water after chewing


See the GL, Appendix II, Orodispersible tablets and the last paragraph:

Other oral formulations such as […] chewable tablets may be handled in a similar way as for ODTs. Bioequivalence studies should be conducted according to the recommended use of the product.


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
105 visitors (0 registered, 105 guests [including 15 identified bots]).
Forum time: 16:52 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5